Time to reconsider the role of sentinel lymph node biopsy in melanoma

被引：23

作者：

Bigby, Michael ^{[1
,2
]}

Zagarella, Samuel ^{[3
]}

Sladden, Michael ^{[4
]}

Popescu, Catalin M. ^{[5
]}

机构：

[1] Harvard Med Sch, Dept Dermatol, Boston, MA 02215 USA

[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[3] Univ Sydney, Dept Dermatol, Sch Med, Sydney, NSW, Australia

[4] Univ Tasmania, Dept Med, Sch Med, Launceston, Tas, Australia

[5] Carol Davila Univ Med & Pharm, Bucharest, Romania

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 04期

关键词：

Breslow thickness; hazard ration; immediate completion lymph node dissection; melanoma; multicenter selective lymphadenectomy trial; prognosis; sentinel lymph node biopsy; survival; PROGNOSTIC VALUE; SURVIVAL;

D O I：

10.1016/j.jaad.2018.11.026

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The Multicenter Selective Lymphadenectomy Trials indicate that there are no overall or melanoma-specific survival advantages to performing sentinel lymph node biopsy (SLNB) followed by immediate completion lymph node dissection compared with wide excision and observation for patients with positive sentinel nodes. These results make SLNB solely a staging procedure. The role of SLNB in the management of patients with melanoma deserves reappraisal. The potential marginal benefit of SLNB beyond the clinical and pathologic features of the melanoma has not been well studied. The use of sentinel lymph node status alone to accept and stratify patients into trials or to receive adjuvant treatment is not rational.

引用

页码：1168 / 1171

页数：4

共 50 条

[41] Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma
Gyorki, DE
Busam, K
Panageas, K
Brady, MS
Coit, DG
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (04) : 403 - 407
[42] Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma
van Akkooi, Alexander C. J.
Schadendorf, Dirk
Eggermont, Alexander M. M.
EUROPEAN JOURNAL OF CANCER, 2023, 182 : 163 - 169
[43] Acral lentiginous melanoma: Who benefits from sentinel lymph node biopsy?
Ito, Takamichi
Wada, Maiko
Nagae, Konosuke
Nakano-Nakamura, Misa
Nakahara, Takeshi
Hagihara, Akihito
Furue, Masutaka
Uchi, Hiroshi
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (01) : 71 - 77
[44] Predictors and patterns of melanoma recurrence following a negative sentinel lymph node biopsy
O'Connell, Emer P.
O'Leary, Donal P.
Fogarty, Katrina
Khan, Zeb J.
Redmond, Henry P.
MELANOMA RESEARCH, 2016, 26 (01) : 66 - 70
[45] Role of Sentinel Lymph Node Biopsy in Patients with Thin Melanoma
Andtbacka, Robert H. I.
Gershenwald, Jeffrey E.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (03): : 308 - 317
[46] Sentinel node biopsy for skin melanoma
Kovacevic, Predrag
Visnjic, Milan
Vlajkovic, Marina
Kovacevic, Tatjana
Visnjic, Aleksandar
VOJNOSANITETSKI PREGLED, 2009, 66 (08) : 657 - 662
[47] The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients
Tejera-Vaquerizo, Antonio
Descalzo-Gallego, Miguel Angel
Traves, Victor
Requena, Celia
Bolumar, Isidro
Pla, Angel
Nagore, Eduardo
EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (05) : 487 - 495
[48] The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients
Antonio Tejera-Vaquerizo
Miguel Angel Descalzo-Gallego
Victor Traves
Celia Requena
Isidro Bolumar
Angel Pla
Eduardo Nagore
European Journal of Dermatology, 2017, 27 : 487 - 495
[49] Cost Analysis of Sentinel Lymph Node Biopsy in Melanoma
Martinez-Menchon, T.
Sanchez-Pedreno, P.
Martinez-Escribano, J.
Corbalan-Velez, R.
Martinez-Barba, E.
ACTAS DERMO-SIFILIOGRAFICAS, 2015, 106 (03): : 201 - 207
[50] Sentinel Lymph Node Biopsy in Melanoma: Assessment of Risk
Ausilia Maria Manganoni
Camillo Farisoglio
Fabio Facchetti
Edda Simoncini
Pier Giacomo Calzavara Pinton
Annals of Surgical Oncology, 2008, 15 : 2626 - 2626

← 1 2 3 4 5 →